Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
- PMID: 17200671
- DOI: 10.1038/ng1947
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Abstract
PALB2 was recently identified as a nuclear binding partner of BRCA2. Biallelic BRCA2 mutations cause Fanconi anemia subtype FA-D1 and predispose to childhood malignancies. We identified pathogenic mutations in PALB2 (also known as FANCN) in seven families affected with Fanconi anemia and cancer in early childhood, demonstrating that biallelic PALB2 mutations cause a new subtype of Fanconi anemia, FA-N, and, similar to biallelic BRCA2 mutations, confer a high risk of childhood cancer.
Comment in
-
Fanconi anemia and breast cancer susceptibility.Nat Genet. 2007 Feb;39(2):142-3. doi: 10.1038/ng0207-142. Nat Genet. 2007. PMID: 17262024 No abstract available.
Similar articles
-
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.Nat Genet. 2007 Feb;39(2):159-61. doi: 10.1038/ng1942. Epub 2006 Dec 31. Nat Genet. 2007. PMID: 17200672
-
PALB2/FANCN: recombining cancer and Fanconi anemia.Cancer Res. 2010 Oct 1;70(19):7353-9. doi: 10.1158/0008-5472.CAN-10-1012. Epub 2010 Sep 21. Cancer Res. 2010. PMID: 20858716 Free PMC article. Review.
-
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.Nat Genet. 2007 Feb;39(2):165-7. doi: 10.1038/ng1959. Epub 2006 Dec 31. Nat Genet. 2007. PMID: 17200668 Free PMC article.
-
Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.Breast Cancer Res Treat. 2009 Feb;113(3):545-51. doi: 10.1007/s10549-008-9945-0. Epub 2008 Feb 27. Breast Cancer Res Treat. 2009. PMID: 18302019
-
Exploring the roles of PALB2 at the crossroads of DNA repair and cancer.Biochem J. 2014 Jun 15;460(3):331-42. doi: 10.1042/BJ20140208. Biochem J. 2014. PMID: 24870022 Review.
Cited by
-
Understanding familial risk of pancreatic ductal adenocarcinoma.Fam Cancer. 2024 Apr 12. doi: 10.1007/s10689-024-00383-2. Online ahead of print. Fam Cancer. 2024. PMID: 38609521 Review.
-
PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling.Cell Mol Life Sci. 2024 Apr 10;81(1):173. doi: 10.1007/s00018-024-05183-6. Cell Mol Life Sci. 2024. PMID: 38597967 Free PMC article.
-
Whole exome sequencing of a novel homozygous missense variant in PALB2 gene leading to Fanconi anaemia complementation group.Biomed Rep. 2024 Mar 1;20(4):67. doi: 10.3892/br.2024.1756. eCollection 2024 Apr. Biomed Rep. 2024. PMID: 38476606 Free PMC article.
-
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.Bone Marrow Transplant. 2024 Jun;59(6):717-741. doi: 10.1038/s41409-023-02190-2. Epub 2024 Feb 27. Bone Marrow Transplant. 2024. PMID: 38413823 Review.
-
FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia.Blood Adv. 2024 Feb 27;8(4):899-908. doi: 10.1182/bloodadvances.2023011888. Blood Adv. 2024. PMID: 38191666 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous